EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access · CC BY-NC-ND 4.0

Prospective Evaluation of Clinical Outcomes of the Subchondroplasty Procedure for Treatment of Symptomatic Bone Marrow Lesions of the Knee

Steven B Cohen, Christopher Hajnik, Gregory J Loren, Sam Akhavan, Patrick J DeMeo, Douglas J Wyland, Thomas Youm, Laith M Jazrawi, Robert J Daley, Jack Farr, Patrick Reischling, Jennifer E Woodell-May iD

The Journal of Knee Surgery · 01.05.2025 · 38 (06) · 290-299

DOI: 10.1055/a-2501-0910 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift The Journal of Knee Surgery, erschienen am 01.05.2025. Verfasst von Steven B Cohen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Rothman Institute at Thomas Jefferson University Hospital, Philadelphia, Pennsylvania. Hauptthemen laut MEDLINE: Bone Substitutes, Bone Marrow Diseases, Knee Joint, Calcium Phosphates. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Zimmer Biomet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bone marrow lesions (BMLs) have a strong correlation to patient-reported pain, functional limitations, joint deterioration, and rapid progression to total knee arthroplasty. The Subchondroplasty (SCP) procedure uses AccuFill, a calcium phosphate bone substitute material (BSM), to treat bone defects such as microtrabecular fractures and BML. This observational, prospective, multicenter, cohort study evaluated the effect of the SCP procedure at the 2-year follow-up for 70 patients with knee BML. Under arthroscopic and fluoroscopic guidance, the BML was injected with AccuFill. Patient-reported outcomes, including Visual Analog Scale (VAS) pain, Knee Injury and Osteoarthritis Outcome Score (KOOS), International Knee Documentation Committee (IKDC), and modified Knee Society Score (mKSS) were collected through 24 months postoperatively. Radiographs and magnetic resonance imaging (MRI) were performed at baseline and up to 24 months postoperatively. Patient selection was not limited based on the degree of osteoarthritis (OA) as determined radiologically by the Kellgren–Lawrence (K-L) grade. For a subset of patients, patient-reported outcomes were collected up to 5 years including pain evaluation, patient knee global assessment, and satisfaction with the procedure. Preoperative radiographs indicated moderate to severe OA (K-L grades 2–4) in 65 patients (92.8%). Significant improvements (p < 0.0001) in mean VAS pain, IKDC, mKSS, and KOOS scores were observed compared with baseline. Kaplan–Meier survivorship free from conversion to knee arthroplasty was 76.2% at 2 years. The subset of patients followed for 5 years demonstrated low pain scores and high procedure satisfaction. This study presents statistically significant and clinically meaningful evidence of improvement in clinical outcomes following SCP for BMLs of the knee after 2 years. The survivorship rate from arthroplasty at 2 years was 76.2%. SCP for BMLs can relieve pain with a minimally invasive procedure and may delay the need for knee arthroplasty. Registration NCT01621893 (ClinicalTrials.gov). Level of Evidence Level II, Prospective Cohort Therapeutic Study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone SubstitutesBone Marrow DiseasesKnee JointCalcium PhosphatesHumansMaleProspective StudiesFemaleMiddle AgedAgedPatient Reported Outcome MeasuresTreatment OutcomePain MeasurementAdultOsteoarthritis, KneeMagnetic Resonance ImagingArthroscopyArthroplasty, Replacement, Knee

Substanzen

Bone SubstitutesCalcium Phosphatescalcium phosphate

Autor:innen und Institutionen

  • Rothman Institute at Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.
  • CORE Orthopaedic Medical Center, Orthopaedic Surgeons, Encinitas, California.
  • Department of Orthopaedic Surgery, Allegheny General Hospital, Pittsburgh, Pennsylvania.
  • Prisma Health Steadman Hawkins Clinic of the Carolinas, Greenville, South Carolina.
  • NYU Hospital for Joint Diseases, New York, New York.
  • Hinsdale Orthopaedics, A Division of Illinois Bone and Joint Institute, Hinsdale, Illinois.

ORCID-Profile: Jennifer E Woodell-May

Förderung

  • Zimmer Biomet

Zitieren

APA

Cohen, S. B., Hajnik, C., Loren, G. J., Akhavan, S., DeMeo, P. J., Wyland, D. J., Youm, T., Jazrawi, L. M., Daley, R. J., Farr, J., Reischling, P., & Woodell-May, J. E. (2025). Prospective Evaluation of Clinical Outcomes of the Subchondroplasty Procedure for Treatment of Symptomatic Bone Marrow Lesions of the Knee. The Journal of Knee Surgery, 38(06), 290-299. https://doi.org/10.1055/a-2501-0910

Vancouver

Cohen SB, Hajnik C, Loren GJ, Akhavan S, DeMeo PJ, Wyland DJ, et al. Prospective Evaluation of Clinical Outcomes of the Subchondroplasty Procedure for Treatment of Symptomatic Bone Marrow Lesions of the Knee. The Journal of Knee Surgery. 2025;38(06):290-299. doi:10.1055/a-2501-0910

BibTeX
@article{Cohen2025,
  author = {Cohen, Steven B and Hajnik, Christopher and Loren, Gregory J and Akhavan, Sam and DeMeo, Patrick J and Wyland, Douglas J and Youm, Thomas and Jazrawi, Laith M and Daley, Robert J and Farr, Jack and Reischling, Patrick and Woodell-May, Jennifer E},
  title = {Prospective Evaluation of Clinical Outcomes of the Subchondroplasty Procedure for Treatment of Symptomatic Bone Marrow Lesions of the Knee},
  journal = {The Journal of Knee Surgery},
  year = {2025},
  volume = {38},
  number = {06},
  pages = {290--299},
  doi = {10.1055/a-2501-0910}
}
Kostenlos starten →